Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a group therapy tackle both depression and anxiety in teens?

NCT ID NCT01829100

Symptom relief Sponsor: Rutgers University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study investigates how avoidance behaviors contribute to depression and anxiety in teenagers, and tests a group therapy called Group Behavioral Activation Therapy (GBAT). The therapy involves 15 weekly sessions teaching skills to understand and change avoidance patterns. Researchers will compare 35 seventh and eighth graders with depression and anxiety to a non-clinical group, using electronic diaries to track daily experiences. The goal is to see if GBAT can reduce symptoms and improve functioning.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Group Behavioral Activation Therapy (GBAT) — a behavioral therapy involving 15 weekly group sessions teaching skills like psychoeducation, functional analysis, problem solving, and graded exposures.
What this could lead to
If successful, this therapy could offer an effective, school-based treatment for teens with both depression and anxiety, potentially improving outcomes and reducing the need for more intensive care.
What could go wrong
This is a small pilot study with only 35 participants, so results may not apply to all teens. The therapy may not work better than existing treatments, and long-term benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

895 people

The number who actually took part.

Start date

Sep 2009

Finished

Jun 2012

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

11 to 15 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * clinical (ADIS CSR ≥ 4) or subclinical (ADIS CSR = 2-3) principal diagnosis of either a DSM-IV-TR unipolar depression disorder (Major Depressive Disorder (\[MDD\], Minor Depression \[MinD\], or Dysthymia \[Dys\]) or * an anxiety disorder (Generalized Anxiety Disorder \[GAD\], Social Phobia \[SOP\], Separation Anxiety \[SAD\]). Exclusion Criteria: * any principal diagnosis other than anxiety or depression or parent report of mental retardation, * pervasive developmental disorder, * schizophrenia, or * bipolar disorder, or * report of past-year hospitalization for a suicide attempt. Concurrent use of antidepressant or anxiolytic medications was permitted as long as dosage was stable for at least four weeks and the family intended to maintain the dose.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety disorders are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder depressive disorder dysthymic disorder generalized anxiety disorder major depressive disorder separation anxiety disorder social phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety disorders Depressive disorder

Contacts and locations

Locations

  • Rutgers University

    Piscataway, New Jersey, 08854, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.